The global market for Heparin Sodium was estimated to be worth US$ 3374.8 million in 2023 and is forecast to a readjusted size of US$ 4200.7 million by 2030 with a CAGR of 6.2% during the forecast period 2024-2030

Heparin Sodium - Market

Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.

Global Heparin Sodium key players include Shenzhen Hepalink, Bioibérica, Nanjing King-friend, Changshan Biochemical and Dongcheng Biochemicals. Global top five manufacturers hold a share about 57%. Europe is the largest market, with a share about 55%, followed by China and North America, total with a share about 35 percent. In terms of application, the largest application is Low Molecular Weight Heparin Preparations, followed by Standard Heparin Preparation.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Heparin Sodium, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Heparin Sodium by region & country, by Type, and by Application.

The Heparin Sodium market size, estimations, and forecasts are provided in terms of sales volume (Million Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin Sodium.

Market Segmentation

Scope of Heparin Sodium - Market Report

Report Metric	Details
Report Name	Heparin Sodium - Market
Forecasted market size in 2030	US$ 4200.7 million
CAGR	6.2%
Forecasted years	2024 - 2030
Segment by Type:	Type A Type B
Segment by Application	Standard Heparin Preparation Low Molecular Weight Heparin Preparations
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Shenzhen Hepalink, Nanjing King-friend, Bioiberica, Dongcheng Biochemicals, Changzhou Qianhong Bio-pharma, Pfizer, Changshan Biochemical, Aspen Oss, Opocrin, Qingdao Jiulong Biopharmaceutical, Yino Pharma Limited, Dongying Tiandong Pharmaceutical, Xinbai Pharmaceuticals, Laboratorios Farmaceuticos ROVI, Sichuan Deebio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Heparin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Heparin Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Heparin Sodium in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Heparin Sodium - Market size in 2030?

Ans: The Heparin Sodium - Market size in 2030 will be US$ 4200.7 million.

What is the market share of major companies in Heparin Sodium - Market?

Ans: Global top five manufacturers hold a share about 57%.

Who are the main players in the Heparin Sodium - Market report?

Ans: The main players in the Heparin Sodium - Market are Shenzhen Hepalink, Nanjing King-friend, Bioiberica, Dongcheng Biochemicals, Changzhou Qianhong Bio-pharma, Pfizer, Changshan Biochemical, Aspen Oss, Opocrin, Qingdao Jiulong Biopharmaceutical, Yino Pharma Limited, Dongying Tiandong Pharmaceutical, Xinbai Pharmaceuticals, Laboratorios Farmaceuticos ROVI, Sichuan Deebio

What are the Application segmentation covered in the Heparin Sodium - Market report?

Ans: The Applications covered in the Heparin Sodium - Market report are Standard Heparin Preparation, Low Molecular Weight Heparin Preparations

What are the Type segmentation covered in the Heparin Sodium - Market report?

Ans: The Types covered in the Heparin Sodium - Market report are Type A, Type B

1 Market Overview

1.1 Heparin Sodium Product Introduction

1.2 Global Heparin Sodium Market Size Forecast

1.2.1 Global Heparin Sodium Sales Value (2019-2030)

1.2.2 Global Heparin Sodium Sales Volume (2019-2030)

1.2.3 Global Heparin Sodium Sales Price (2019-2030)

1.3 Heparin Sodium Market Trends & Drivers

1.3.1 Heparin Sodium Industry Trends

1.3.2 Heparin Sodium Market Drivers & Opportunity

1.3.3 Heparin Sodium Market Challenges

1.3.4 Heparin Sodium Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Heparin Sodium Players Revenue Ranking (2023)

2.2 Global Heparin Sodium Revenue by Company (2019-2024)

2.3 Global Heparin Sodium Players Sales Volume Ranking (2023)

2.4 Global Heparin Sodium Sales Volume by Company Players (2019-2024)

2.5 Global Heparin Sodium Average Price by Company (2019-2024)

2.6 Key Manufacturers Heparin Sodium Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Heparin Sodium Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Heparin Sodium

2.9 Heparin Sodium Market Competitive Analysis

2.9.1 Heparin Sodium Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Heparin Sodium Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin Sodium as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Type A

3.1.2 Type B

3.2 Global Heparin Sodium Sales Value by Type

3.2.1 Global Heparin Sodium Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Heparin Sodium Sales Value, by Type (2019-2030)

3.2.3 Global Heparin Sodium Sales Value, by Type (%) (2019-2030)

3.3 Global Heparin Sodium Sales Volume by Type

3.3.1 Global Heparin Sodium Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Heparin Sodium Sales Volume, by Type (2019-2030)

3.3.3 Global Heparin Sodium Sales Volume, by Type (%) (2019-2030)

3.4 Global Heparin Sodium Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Standard Heparin Preparation

4.1.2 Low Molecular Weight Heparin Preparations

4.2 Global Heparin Sodium Sales Value by Application

4.2.1 Global Heparin Sodium Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Heparin Sodium Sales Value, by Application (2019-2030)

4.2.3 Global Heparin Sodium Sales Value, by Application (%) (2019-2030)

4.3 Global Heparin Sodium Sales Volume by Application

4.3.1 Global Heparin Sodium Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Heparin Sodium Sales Volume, by Application (2019-2030)

4.3.3 Global Heparin Sodium Sales Volume, by Application (%) (2019-2030)

4.4 Global Heparin Sodium Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Heparin Sodium Sales Value by Region

5.1.1 Global Heparin Sodium Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Heparin Sodium Sales Value by Region (2019-2024)

5.1.3 Global Heparin Sodium Sales Value by Region (2025-2030)

5.1.4 Global Heparin Sodium Sales Value by Region (%), (2019-2030)

5.2 Global Heparin Sodium Sales Volume by Region

5.2.1 Global Heparin Sodium Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Heparin Sodium Sales Volume by Region (2019-2024)

5.2.3 Global Heparin Sodium Sales Volume by Region (2025-2030)

5.2.4 Global Heparin Sodium Sales Volume by Region (%), (2019-2030)

5.3 Global Heparin Sodium Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Heparin Sodium Sales Value, 2019-2030

5.4.2 North America Heparin Sodium Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Heparin Sodium Sales Value, 2019-2030

5.5.2 Europe Heparin Sodium Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Heparin Sodium Sales Value, 2019-2030

5.6.2 Asia Pacific Heparin Sodium Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Heparin Sodium Sales Value, 2019-2030

5.7.2 South America Heparin Sodium Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Heparin Sodium Sales Value, 2019-2030

5.8.2 Middle East & Africa Heparin Sodium Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Heparin Sodium Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Heparin Sodium Sales Value

6.2.1 Key Countries/Regions Heparin Sodium Sales Value, 2019-2030

6.2.2 Key Countries/Regions Heparin Sodium Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Heparin Sodium Sales Value, 2019-2030

6.3.2 United States Heparin Sodium Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Heparin Sodium Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Heparin Sodium Sales Value, 2019-2030

6.4.2 Europe Heparin Sodium Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Heparin Sodium Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Heparin Sodium Sales Value, 2019-2030

6.5.2 China Heparin Sodium Sales Value by Type (%), 2023 VS 2030

6.5.3 China Heparin Sodium Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Heparin Sodium Sales Value, 2019-2030

6.6.2 Japan Heparin Sodium Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Heparin Sodium Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Heparin Sodium Sales Value, 2019-2030

6.7.2 South Korea Heparin Sodium Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Heparin Sodium Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Heparin Sodium Sales Value, 2019-2030

6.8.2 Southeast Asia Heparin Sodium Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Heparin Sodium Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Heparin Sodium Sales Value, 2019-2030

6.9.2 India Heparin Sodium Sales Value by Type (%), 2023 VS 2030

6.9.3 India Heparin Sodium Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Shenzhen Hepalink

7.1.1 Shenzhen Hepalink Company Information

7.1.2 Shenzhen Hepalink Introduction and Business Overview

7.1.3 Shenzhen Hepalink Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Shenzhen Hepalink Heparin Sodium Product Offerings

7.1.5 Shenzhen Hepalink Recent Development

7.2 Nanjing King-friend

7.2.1 Nanjing King-friend Company Information

7.2.2 Nanjing King-friend Introduction and Business Overview

7.2.3 Nanjing King-friend Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Nanjing King-friend Heparin Sodium Product Offerings

7.2.5 Nanjing King-friend Recent Development

7.3 Bioiberica

7.3.1 Bioiberica Company Information

7.3.2 Bioiberica Introduction and Business Overview

7.3.3 Bioiberica Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Bioiberica Heparin Sodium Product Offerings

7.3.5 Bioiberica Recent Development

7.4 Dongcheng Biochemicals

7.4.1 Dongcheng Biochemicals Company Information

7.4.2 Dongcheng Biochemicals Introduction and Business Overview

7.4.3 Dongcheng Biochemicals Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Dongcheng Biochemicals Heparin Sodium Product Offerings

7.4.5 Dongcheng Biochemicals Recent Development

7.5 Changzhou Qianhong Bio-pharma

7.5.1 Changzhou Qianhong Bio-pharma Company Information

7.5.2 Changzhou Qianhong Bio-pharma Introduction and Business Overview

7.5.3 Changzhou Qianhong Bio-pharma Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Changzhou Qianhong Bio-pharma Heparin Sodium Product Offerings

7.5.5 Changzhou Qianhong Bio-pharma Recent Development

7.6 Pfizer

7.6.1 Pfizer Company Information

7.6.2 Pfizer Introduction and Business Overview

7.6.3 Pfizer Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Pfizer Heparin Sodium Product Offerings

7.6.5 Pfizer Recent Development

7.7 Changshan Biochemical

7.7.1 Changshan Biochemical Company Information

7.7.2 Changshan Biochemical Introduction and Business Overview

7.7.3 Changshan Biochemical Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Changshan Biochemical Heparin Sodium Product Offerings

7.7.5 Changshan Biochemical Recent Development

7.8 Aspen Oss

7.8.1 Aspen Oss Company Information

7.8.2 Aspen Oss Introduction and Business Overview

7.8.3 Aspen Oss Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Aspen Oss Heparin Sodium Product Offerings

7.8.5 Aspen Oss Recent Development

7.9 Opocrin

7.9.1 Opocrin Company Information

7.9.2 Opocrin Introduction and Business Overview

7.9.3 Opocrin Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Opocrin Heparin Sodium Product Offerings

7.9.5 Opocrin Recent Development

7.10 Qingdao Jiulong Biopharmaceutical

7.10.1 Qingdao Jiulong Biopharmaceutical Company Information

7.10.2 Qingdao Jiulong Biopharmaceutical Introduction and Business Overview

7.10.3 Qingdao Jiulong Biopharmaceutical Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Qingdao Jiulong Biopharmaceutical Heparin Sodium Product Offerings

7.10.5 Qingdao Jiulong Biopharmaceutical Recent Development

7.11 Yino Pharma Limited

7.11.1 Yino Pharma Limited Company Information

7.11.2 Yino Pharma Limited Introduction and Business Overview

7.11.3 Yino Pharma Limited Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Yino Pharma Limited Heparin Sodium Product Offerings

7.11.5 Yino Pharma Limited Recent Development

7.12 Dongying Tiandong Pharmaceutical

7.12.1 Dongying Tiandong Pharmaceutical Company Information

7.12.2 Dongying Tiandong Pharmaceutical Introduction and Business Overview

7.12.3 Dongying Tiandong Pharmaceutical Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Dongying Tiandong Pharmaceutical Heparin Sodium Product Offerings

7.12.5 Dongying Tiandong Pharmaceutical Recent Development

7.13 Xinbai Pharmaceuticals

7.13.1 Xinbai Pharmaceuticals Company Information

7.13.2 Xinbai Pharmaceuticals Introduction and Business Overview

7.13.3 Xinbai Pharmaceuticals Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Xinbai Pharmaceuticals Heparin Sodium Product Offerings

7.13.5 Xinbai Pharmaceuticals Recent Development

7.14 Laboratorios Farmaceuticos ROVI

7.14.1 Laboratorios Farmaceuticos ROVI Company Information

7.14.2 Laboratorios Farmaceuticos ROVI Introduction and Business Overview

7.14.3 Laboratorios Farmaceuticos ROVI Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Laboratorios Farmaceuticos ROVI Heparin Sodium Product Offerings

7.14.5 Laboratorios Farmaceuticos ROVI Recent Development

7.15 Sichuan Deebio

7.15.1 Sichuan Deebio Company Information

7.15.2 Sichuan Deebio Introduction and Business Overview

7.15.3 Sichuan Deebio Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)

7.15.4 Sichuan Deebio Heparin Sodium Product Offerings

7.15.5 Sichuan Deebio Recent Development

8 Industry Chain Analysis

8.1 Heparin Sodium Industrial Chain

8.2 Heparin Sodium Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Heparin Sodium Sales Model

8.5.2 Sales Channel

8.5.3 Heparin Sodium Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Shenzhen Hepalink

Nanjing King-friend

Dongcheng Biochemicals

Changzhou Qianhong Bio-pharma

Changshan Biochemical

Dongying Tiandong Pharmaceutical

Xinbai Pharmaceuticals

Qingdao Jiulong Biopharmaceutical

Laboratorios Farmaceuticos Rovi

List of Tables

Table 1. Heparin Sodium Market Trends

Table 2. Heparin Sodium Market Drivers & Opportunity

Table 3. Heparin Sodium Market Challenges

Table 4. Heparin Sodium Market Restraints

Table 5. Global Heparin Sodium Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Heparin Sodium Revenue Market Share by Company (2019-2024)

Table 7. Global Heparin Sodium Sales Volume by Company (2019-2024) & (Million Units)

Table 8. Global Heparin Sodium Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Heparin Sodium Price by Company (2019-2024) & (USD/Million Units)

Table 10. Key Manufacturers Heparin Sodium Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Heparin Sodium Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Heparin Sodium

Table 13. Global Heparin Sodium Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin Sodium as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Heparin Sodium Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Heparin Sodium Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Heparin Sodium Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Heparin Sodium Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Heparin Sodium Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Heparin Sodium Sales Volume by Type: 2019 VS 2023 VS 2030 (Million Units)

Table 22. Global Heparin Sodium Sales Volume by Type (2019-2024) & (Million Units)

Table 23. Global Heparin Sodium Sales Volume by Type (2025-2030) & (Million Units)

Table 24. Global Heparin Sodium Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Heparin Sodium Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Heparin Sodium Price by Type (2019-2024) & (USD/Million Units)

Table 27. Global Heparin Sodium Price by Type (2025-2030) & (USD/Million Units)

Table 28. Global Heparin Sodium Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Heparin Sodium Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Heparin Sodium Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Heparin Sodium Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Heparin Sodium Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Heparin Sodium Sales Volume by Application: 2019 VS 2023 VS 2030 (Million Units)

Table 34. Global Heparin Sodium Sales Volume by Application (2019-2024) & (Million Units)

Table 35. Global Heparin Sodium Sales Volume by Application (2025-2030) & (Million Units)

Table 36. Global Heparin Sodium Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Heparin Sodium Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Heparin Sodium Price by Application (2019-2024) & (USD/Million Units)

Table 39. Global Heparin Sodium Price by Application (2025-2030) & (USD/Million Units)

Table 40. Global Heparin Sodium Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Heparin Sodium Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Heparin Sodium Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Heparin Sodium Sales Value by Region (2019-2024) & (%)

Table 44. Global Heparin Sodium Sales Value by Region (2025-2030) & (%)

Table 45. Global Heparin Sodium Sales Volume by Region (Million Units): 2019 VS 2023 VS 2030

Table 46. Global Heparin Sodium Sales Volume by Region (2019-2024) & (Million Units)

Table 47. Global Heparin Sodium Sales Volume by Region (2025-2030) & (Million Units)

Table 48. Global Heparin Sodium Sales Volume by Region (2019-2024) & (%)

Table 49. Global Heparin Sodium Sales Volume by Region (2025-2030) & (%)

Table 50. Global Heparin Sodium Average Price by Region (2019-2024) & (USD/Million Units)

Table 51. Global Heparin Sodium Average Price by Region (2025-2030) & (USD/Million Units)

Table 52. Key Countries/Regions Heparin Sodium Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Heparin Sodium Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Heparin Sodium Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Heparin Sodium Sales Volume, (2019-2024) & (Million Units)

Table 56. Key Countries/Regions Heparin Sodium Sales Volume, (2025-2030) & (Million Units)

Table 57. Shenzhen Hepalink Company Information

Table 58. Shenzhen Hepalink Introduction and Business Overview

Table 59. Shenzhen Hepalink Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)

Table 60. Shenzhen Hepalink Heparin Sodium Product Offerings

Table 61. Shenzhen Hepalink Recent Development

Table 62. Nanjing King-friend Company Information

Table 63. Nanjing King-friend Introduction and Business Overview

Table 64. Nanjing King-friend Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)

Table 65. Nanjing King-friend Heparin Sodium Product Offerings

Table 66. Nanjing King-friend Recent Development

Table 67. Bioiberica Company Information

Table 68. Bioiberica Introduction and Business Overview

Table 69. Bioiberica Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)

Table 70. Bioiberica Heparin Sodium Product Offerings

Table 71. Bioiberica Recent Development

Table 72. Dongcheng Biochemicals Company Information

Table 73. Dongcheng Biochemicals Introduction and Business Overview

Table 74. Dongcheng Biochemicals Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)

Table 75. Dongcheng Biochemicals Heparin Sodium Product Offerings

Table 76. Dongcheng Biochemicals Recent Development

Table 77. Changzhou Qianhong Bio-pharma Company Information

Table 78. Changzhou Qianhong Bio-pharma Introduction and Business Overview

Table 79. Changzhou Qianhong Bio-pharma Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)

Table 80. Changzhou Qianhong Bio-pharma Heparin Sodium Product Offerings

Table 81. Changzhou Qianhong Bio-pharma Recent Development

Table 82. Pfizer Company Information

Table 83. Pfizer Introduction and Business Overview

Table 84. Pfizer Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)

Table 85. Pfizer Heparin Sodium Product Offerings

Table 86. Pfizer Recent Development

Table 87. Changshan Biochemical Company Information

Table 88. Changshan Biochemical Introduction and Business Overview

Table 89. Changshan Biochemical Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)

Table 90. Changshan Biochemical Heparin Sodium Product Offerings

Table 91. Changshan Biochemical Recent Development

Table 92. Aspen Oss Company Information

Table 93. Aspen Oss Introduction and Business Overview

Table 94. Aspen Oss Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)

Table 95. Aspen Oss Heparin Sodium Product Offerings

Table 96. Aspen Oss Recent Development

Table 97. Opocrin Company Information

Table 98. Opocrin Introduction and Business Overview

Table 99. Opocrin Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)

Table 100. Opocrin Heparin Sodium Product Offerings

Table 101. Opocrin Recent Development

Table 102. Qingdao Jiulong Biopharmaceutical Company Information

Table 103. Qingdao Jiulong Biopharmaceutical Introduction and Business Overview

Table 104. Qingdao Jiulong Biopharmaceutical Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)

Table 105. Qingdao Jiulong Biopharmaceutical Heparin Sodium Product Offerings

Table 106. Qingdao Jiulong Biopharmaceutical Recent Development

Table 107. Yino Pharma Limited Company Information

Table 108. Yino Pharma Limited Introduction and Business Overview

Table 109. Yino Pharma Limited Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)

Table 110. Yino Pharma Limited Heparin Sodium Product Offerings

Table 111. Yino Pharma Limited Recent Development

Table 112. Dongying Tiandong Pharmaceutical Company Information

Table 113. Dongying Tiandong Pharmaceutical Introduction and Business Overview

Table 114. Dongying Tiandong Pharmaceutical Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)

Table 115. Dongying Tiandong Pharmaceutical Heparin Sodium Product Offerings

Table 116. Dongying Tiandong Pharmaceutical Recent Development

Table 117. Xinbai Pharmaceuticals Company Information

Table 118. Xinbai Pharmaceuticals Introduction and Business Overview

Table 119. Xinbai Pharmaceuticals Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)

Table 120. Xinbai Pharmaceuticals Heparin Sodium Product Offerings

Table 121. Xinbai Pharmaceuticals Recent Development

Table 122. Laboratorios Farmaceuticos ROVI Company Information

Table 123. Laboratorios Farmaceuticos ROVI Introduction and Business Overview

Table 124. Laboratorios Farmaceuticos ROVI Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)

Table 125. Laboratorios Farmaceuticos ROVI Heparin Sodium Product Offerings

Table 126. Laboratorios Farmaceuticos ROVI Recent Development

Table 127. Sichuan Deebio Company Information

Table 128. Sichuan Deebio Introduction and Business Overview

Table 129. Sichuan Deebio Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)

Table 130. Sichuan Deebio Heparin Sodium Product Offerings

Table 131. Sichuan Deebio Recent Development

Table 132. Key Raw Materials Lists

Table 133. Raw Materials Key Suppliers Lists

Table 134. Heparin Sodium Downstream Customers

Table 135. Heparin Sodium Distributors List

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Heparin Sodium Product Picture

Figure 2. Global Heparin Sodium Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Heparin Sodium Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Heparin Sodium Sales Volume (2019-2030) & (Million Units)

Figure 5. Global Heparin Sodium Sales Price (2019-2030) & (USD/Million Units)

Figure 6. Heparin Sodium Report Years Considered

Figure 7. Global Heparin Sodium Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Heparin Sodium Players Sales Volume Ranking (2023) & (Million Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Heparin Sodium Revenue in 2023

Figure 10. Heparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Type A Picture

Figure 12. Type B Picture

Figure 13. Global Heparin Sodium Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Heparin Sodium Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Heparin Sodium Sales Volume by Type (2019 VS 2023 VS 2030) & (Million Units)

Figure 16. Global Heparin Sodium Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Heparin Sodium Price by Type (2019-2030) & (USD/Million Units)

Figure 18. Product Picture of Standard Heparin Preparation

Figure 19. Product Picture of Low Molecular Weight Heparin Preparations

Figure 20. Global Heparin Sodium Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Heparin Sodium Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Heparin Sodium Sales Volume by Application (2019 VS 2023 VS 2030) & (Million Units)

Figure 23. Global Heparin Sodium Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Heparin Sodium Price by Application (2019-2030) & (USD/Million Units)

Figure 25. North America Heparin Sodium Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Heparin Sodium Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Heparin Sodium Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Heparin Sodium Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Heparin Sodium Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Heparin Sodium Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Heparin Sodium Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Heparin Sodium Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Heparin Sodium Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Heparin Sodium Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Heparin Sodium Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Heparin Sodium Sales Volume (%), (2019-2030)

Figure 37. United States Heparin Sodium Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Heparin Sodium Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Heparin Sodium Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Heparin Sodium Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Heparin Sodium Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Heparin Sodium Sales Value by Application (%), 2023 VS 2030

Figure 43. China Heparin Sodium Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Heparin Sodium Sales Value by Type (%), 2023 VS 2030

Figure 45. China Heparin Sodium Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Heparin Sodium Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Heparin Sodium Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Heparin Sodium Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Heparin Sodium Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Heparin Sodium Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Heparin Sodium Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Heparin Sodium Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Heparin Sodium Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Heparin Sodium Sales Value by Application (%), 2023 VS 2030

Figure 55. India Heparin Sodium Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Heparin Sodium Sales Value by Type (%), 2023 VS 2030

Figure 57. India Heparin Sodium Sales Value by Application (%), 2023 VS 2030

Figure 58. Heparin Sodium Industrial Chain

Figure 59. Heparin Sodium Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions